The Enterprise Value as of November 2024 (TTM) for Vertex Pharmaceuticals Incorporated (VRTX) is 118.38B

According to Vertex Pharmaceuticals Incorporated’s latest financial reports and current stock price. The company's current Enterprise Value is 118.38B. This represents a change of 20.57% compared to the average of 98.19B of the last 4 quarters.

Vertex Pharmaceuticals Incorporated (VRTX) Historical Enterprise Value (quarterly & annually)

How has VRTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Vertex Pharmaceuticals Incorporated over the last ten years is 47.17B. The current 118.38B Enterprise Value has changed 25.00% with respect to the historical average. Over the past ten years (40 quarters), VRTX's Enterprise Value was at its highest in in the June 2024 quarter at 117.98B. The Enterprise Value was at its lowest in in the December 2016 quarter at 17.74B.

Vertex Pharmaceuticals Incorporated (VRTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vertex Pharmaceuticals Incorporated Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vertex Pharmaceuticals Incorporated (VRTX) Average Enterprise Value

How has VRTX Enterprise Value performed in the past?

The current Enterprise Value of Vertex Pharmaceuticals Incorporated (VRTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Vertex Pharmaceuticals Incorporated (VRTX) Enterprise Value vs. Peers

How is VRTX’s Enterprise Value compared to its peers?

Vertex Pharmaceuticals Incorporated’s Enterprise Value is greater than BioMarin Pharmaceutical Inc. (-68240616170.00), greater than Sarepta Therapeutics, Inc. (12.72B), greater than Seagen Inc. (42.84B), greater than Alnylam Pharmaceuticals, Inc. (35.02B), greater than Intellia Therapeutics, Inc. (1.51B), greater than Editas Medicine, Inc. (211.79M), greater than Beam Therapeutics Inc. (1.88B), greater than Ginkgo Bioworks Holdings, Inc. (143.59M), greater than BioNTech SE (13.68B), greater than Moderna, Inc. (18.10B), greater than Regeneron Pharmaceuticals, Inc. (90.55B), greater than Viking Therapeutics, Inc. (6.99B), greater than PTC Therapeutics, Inc. (2.85B), greater than Reata Pharmaceuticals, Inc. (6.68B), greater than Intercept Pharmaceuticals, Inc. (915.81M), greater than Krystal Biotech, Inc. (4.54B), greater than Madrigal Pharmaceuticals, Inc. (6.99B), greater than CRISPR Therapeutics AG (4.06B), greater than Caribou Biosciences, Inc. (200.91M), greater than Verve Therapeutics, Inc. (442.96M),

Build a custom stock screener for Vertex Pharmaceuticals Incorporated (VRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vertex Pharmaceuticals Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vertex Pharmaceuticals Incorporated (VRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vertex Pharmaceuticals Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.